Ovarian germ cell tumor
MONDO:0011366A neoplasm that arises from the ovary and originates from germ cells. Representative examples include teratoma, embryonal carcinoma, yolk sac tumor, and dysgerminoma.
Also known as: germ cell neoplasm of ovary, germ cell neoplasm of the ovary, germ cell tumor of ovary, germ cell tumor of the ovary, germ cell tumour of ovary, germ cell tumour of the ovary, ovarian germ cell neoplasm, ovarian germ cell tumor
1448 clinical trials for this condition and its sub-types, 9 tagged with Ovarian germ cell tumor itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Ovarian germ cell tumor
-
Malignant germ cell tumor of ovary 2 trials · 4 incl. sub-types
4 sub-types
- Ovarian primitive germ cell tumor 0 trials · 2 incl. sub-types Sub-types →
- Choriocarcinoma of ovary 1 trial Sub-types →
- Malignant dysgerminomatous germ cell tumor of ovary 0 trials
- Primary non-gestational choriocarcinoma of ovary 0 trials
-
Ovarian teratoma 0 trials · 3 incl. sub-types
3 sub-types
- Childhood teratoma of the ovary 1 trial · 2 incl. sub-types Sub-types →
- Ovarian biphasic or triphasic teratoma 0 trials · 2 incl. sub-types Sub-types →
- Ovarian monodermal teratoma 0 trials Sub-types →
-
Pediatric ovarian germ cell tumor 0 trials · 2 incl. sub-types
5 sub-types
- Childhood teratoma of the ovary 1 trial · 2 incl. sub-types Sub-types →
- Childhood choriocarcinoma of the ovary 0 trials
- Childhood ovarian embryonal carcinoma 0 trials
- Childhood ovarian yolk sac tumor 0 trials
- Pediatric ovarian dysgerminoma 0 trials
-
Ovarian cystic teratoma 0 trials
1 sub-type
- Dermoid cyst of ovary 0 trials
Most studied deeper sub-types
-
New antibody drug enters first human tests for tough cancers
Disease control Recruiting nowThis early-stage trial is testing a new drug called XmAb541 in people with advanced ovarian, endometrial, or germ cell tumors that have not responded to standard treatments. The main goal is to see if the drug is safe and to find the best dose. About 282 participants will receive…
Phase 1 • Sponsor: Xencor, Inc. • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Could a simple pill keep relapsed testicular cancer at bay?
Disease control Recruiting nowThis study is for people with relapsed germ cell tumors (a type of cancer often in the testicles or ovaries) who have already had high-dose chemotherapy and a stem cell transplant. It tests whether taking a daily oral chemotherapy drug called etoposide for a while after treatment…
Phase 2 • Sponsor: Nabil Adra • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New drug duo aims to keep relapsed germ cell cancer in check
Disease control Recruiting nowThis study tests whether taking two drugs (zanzalintinib and oral etoposide) after high-dose chemotherapy can help keep relapsed germ cell tumors from growing. About 38 adults whose cancer has not been cured by standard treatments will participate. The goal is to see if this comb…
Phase 1/2 • Sponsor: Indiana University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Can a nurse check on you from home? new study tests remote monitoring for rare cancers
Knowledge-focused Recruiting nowThis study looks at whether follow-up care for people with rare tumors can be done just as well by a nurse remotely as by a doctor in person. About 88 adults recently diagnosed with a rare tumor will be randomly assigned to either in-person doctor visits or remote nurse check-ins…
Phase 2 • Sponsor: Centre Oscar Lambret • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC